Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 14557659)

2.

Oligodendrocyte maturation is inhibited by bone morphogenetic protein.

See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB.

Mol Cell Neurosci. 2004 Aug;26(4):481-92.

PMID:
15276151
4.

Regulation of cytoskeleton by myelin components: studies on shiverer oligodendrocytes carrying an Mbp transgene.

Dyer CA, Phillbotte T, Wolf MK, Billings-Gagliardi S.

Dev Neurosci. 1997;19(5):395-409.

PMID:
9323460
5.

Oligodendrocyte differentiation is increased in transferrin transgenic mice.

Sow A, Lamant M, Bonny JM, Larvaron P, Piaud O, Lécureuil C, Fontaine I, Saleh MC, Garcia Otin AL, Renou JP, Baron B, Zakin M, Guillou F.

J Neurosci Res. 2006 Feb 15;83(3):403-14.

PMID:
16400659
6.

CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.

Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H.

J Neurosci Res. 2002 Aug 1;69(3):305-17.

PMID:
12125072
7.
8.

In vivo analysis of kallikrein-related peptidase 6 (KLK6) function in oligodendrocyte development and the expression of myelin proteins.

Murakami K, Jiang YP, Tanaka T, Bando Y, Mitrovic B, Yoshida S.

Neuroscience. 2013 Apr 16;236:1-11. doi: 10.1016/j.neuroscience.2012.12.073. Epub 2013 Jan 31.

PMID:
23376368
9.

Thyroid hormone deficiency changes the distribution of oligodendrocyte/myelin markers during oligodendroglial differentiation in vitro.

Younes-Rapozo V, Berendonk J, Savignon T, Manhães AC, Barradas PC.

Int J Dev Neurosci. 2006 Nov;24(7):445-53. Epub 2006 Oct 9.

PMID:
17030110
10.

Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.

Massa PT, Wu C, Fecenko-Tacka K.

J Neurosci Res. 2004 Jul 1;77(1):15-25.

PMID:
15197735
11.

Isolation, culture, and characterization of adult rat oligodendrocytes.

Vick RS, Chen SJ, DeVries GH.

J Neurosci Res. 1990 Apr;25(4):524-34.

PMID:
1693692
12.

HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.

Hanna Z, Priceputu E, Hu C, Vincent P, Jolicoeur P.

Virology. 2006 Mar 1;346(1):40-52. Epub 2005 Nov 28.

13.

Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.

Potzner MR, Griffel C, Lütjen-Drecoll E, Bösl MR, Wegner M, Sock E.

Mol Cell Biol. 2007 Aug;27(15):5316-26. Epub 2007 May 21.

14.

On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter?

Gaupp S, Arezzo J, Dutta DJ, John GR, Raine CS.

J Neuropathol Exp Neurol. 2011 Dec;70(12):1138-50. doi: 10.1097/NEN.0b013e31823b188b.

15.

Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice.

Vincent P, Priceputu E, Kay D, Saksela K, Jolicoeur P, Hanna Z.

J Biol Chem. 2006 Mar 17;281(11):6940-54. Epub 2005 Dec 28.

17.

Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Priceputu E, Hanna Z, Hu C, Simard MC, Vincent P, Wildum S, Schindler M, Kirchhoff F, Jolicoeur P.

J Virol. 2007 May;81(9):4677-93. Epub 2007 Feb 21.

18.

Isolation of oligodendrocyte-like cells from human umbilical cord blood.

Tracy E, Aldrink J, Panosian J, Beam D, Thacker J, Reese M, Kurtzberg J.

Cytotherapy. 2008;10(5):518-25. doi: 10.1080/14653240802154586.

PMID:
18608351
19.

GFAP-positive and myelin marker-positive glia in normal and pathologic environments.

Dyer CA, Kendler A, Jean-Guillaume D, Awatramani R, Lee A, Mason LM, Kamholz J.

J Neurosci Res. 2000 May 1;60(3):412-26.

PMID:
10797544
20.

Subclasses of oligodendrocytes populate the mouse hippocampus.

Vinet J, Lemieux P, Tamburri A, Tiesinga P, Scafidi J, Gallo V, Sík A.

Eur J Neurosci. 2010 Feb;31(3):425-38. doi: 10.1111/j.1460-9568.2010.07082.x. Epub 2010 Jan 25.

PMID:
20105232
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk